News for Imricor Medical Systems, Inc. (IMR.AX)

Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first

Release Date: February 26, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Imricor Medi

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NIMR.AX - Imricor Medical Systems IncFull Year 2024 Imricor Medical Systems Inc Earnings CallFe

The ASX200 closed up 0.45% at 8,444 points after hitting a new high in intra-day trade. The local bourse surged to a record of 8,477 before paring gains

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and...

Total Revenue: $616,000, down 25% compared to the prior year.Consumable Product Sales Revenue: $291,000, down 26% compared to the prior year.Consulting Revenue

Total Revenue: $408,000 for the half year, up 105% compared to the prior corresponding period.Consumable Product Sales Revenue: Approximately $154,000, broadly

Aug 27, 2024 / 10:00PM GMTOperator Morning and welcome to Imricor's first-half investor presentation, which will be released on the ASX imminently from the comp

Mar 18, 2024 / 10:00PM GMTOperator Hello, and welcome to the Special Meeting of Stockholders of Imricor Medical Systems, Incorporated. Please note that today's

Imricor Medical Systems Ltd intends to use the capital raising's funds to support a three-pronged growth strategy.

Aussie markets have somehow pulled of a miracle gain despite two horror sessions this week.

Microba wraps up autoimmune disease therapeutic discovery program with Ginkgo Bioworks and Imricor completes second iCMR ablation in Croatia.

Imricor Medical Systems (ASX: IMR) has been awarded a public tender by Semmelweis University in Hungary for the procurement of an iCMR (interventional

The ASX200 has peaked at a record 7838 points around midday (AEDT). Meanwhile at 2pm, the All Ordinaries index (largest 500 companies) hit 8098 points which is another all time high.

Long-awaited US approval for MVP's Penthrox 'green whistle' closer; Imricor establishes first iCMR lab at the University Hospital Lausanne.

The ASX slid into the murkiest of mires this afternoon, down 0.6% and with barely a handful of standouts to make getting out of bed today worthwhile.

The ASX has rolled into lunch down 0.2%, CleanSpace is up 47% for the morning and the Mystery of the Missing Monkeys has finally been solved.

Which small caps won the ASX in June, two stock picks to stick on your long term watchlist, and Canberra's annual report pumps lithium.

The heart space within healthcare is one of the biggest markets. And these are the ASX heart stocks making major progress.